Axsome Therapeutics, Inc. (AXSM)

NASDAQ: AXSM · Real-Time Price · USD

156.35

-7.92 (-4.82%)

At close: Mar 27, 2026, 4:00 PM EDT

155.50

-0.85 (-0.54%)

After-hours: Mar 27, 2026, 7:21 PM EDT

Axsome Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	7,998	9,293	4,118	3,769	3,355	1,429
Market Cap Growth	37.30%	125.69%	9.26%	12.33%	134.83%	-53.08%
Enterprise Value	7,893	9,185	3,992	3,568	3,248	1,391
Last Close Price	156.35	182.64	84.61	79.59	77.13	37.78
PE Ratio	-	-49.63	-14.13	-15.10	-16.77	-10.89
PS Ratio	12.53	14.55	10.68	13.93	67.05	-
PB Ratio	90.10	105.25	72.22	19.73	30.62	91.41
P/TBV Ratio	88.09	102.90	71.11	18.93	28.62	90.93
P/FCF Ratio	-	-98.99	-32.00	-25.87	-28.62	-13.16
P/OCF Ratio	-	-99.49	-32.07	-25.98	-28.80	-13.20
EV/Sales Ratio	12.36	14.39	10.35	13.18	64.92	-
EV/EBITDA Ratio	-	-58.25	-14.64	-15.86	-18.52	-11.16
EV/EBIT Ratio	-	-55.08	-14.23	-15.39	-18.07	-11.16
EV/FCF Ratio	-	-97.84	-31.02	-24.49	-27.71	-12.82
Debt / Equity Ratio	2.44	2.44	3.33	0.97	0.86	3.14
Debt / EBITDA Ratio	-1.37	-1.37	-0.70	-0.83	-0.54	-0.40
Debt / FCF Ratio	-2.30	-2.30	-1.49	-1.28	-0.81	-0.46
Net Debt / Equity Ratio	-1.22	-1.22	-2.17	-1.05	-0.97	-2.35
Net Debt / EBITDA Ratio	0.68	0.68	0.45	0.89	0.61	0.30
Net Debt / FCF Ratio	1.14	1.14	0.96	1.37	0.91	0.34
Asset Turnover	1.01	1.01	0.67	0.59	0.24	0
Inventory Turnover	2.17	2.17	2.16	2.68	2.41	-
Quick Ratio	1.44	1.44	1.99	3.46	2.47	3.75
Current Ratio	1.55	1.55	2.11	3.63	2.54	3.75
Return on Equity (ROE)	-252.11%	-252.11%	-231.63%	-159.21%	-298.97%	-201.51%
Return on Assets (ROA)	-26.43%	-26.43%	-48.52%	-50.62%	-85.77%	-91.05%
Return on Invested Capital (ROIC)	-327.19%	-327.19%	-539.58%	-418.40%	-1866.52%	606.97%
Return on Capital Employed (ROCE)	-51.36%	-51.36%	-71.23%	-67.76%	-120.01%	-109.67%
Earnings Yield	-2.29%	-2.01%	-7.08%	-6.62%	-5.96%	-9.18%
FCF Yield	-1.17%	-1.01%	-3.12%	-3.87%	-3.49%	-7.60%
Buyback Yield / Dilution	-3.82%	-3.83%	-5.48%	-11.73%	-8.07%	-1.11%
Total Shareholder Return	-3.82%	-3.83%	-5.48%	-11.73%	-8.07%	-1.11%

Updated Feb 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q